Traditional Chinese medicine composition for treating chronic renal failure and application thereof
By combining the traditional Chinese medicine ingredients of Qixiandanhuang Decoction, the problems of complex formulation and unclear mechanism in the treatment of chronic renal failure with traditional Chinese medicine have been solved. It has achieved the effects of significantly reducing blood urea nitrogen, serum creatinine and proteinuria, relieving micro-inflammation and protecting renal function.
Patent Information
- Application Number
- CN202610705930.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-21
- Publication Date
- 2026-06-26
- Estimated Expiration
- 2046-05-21
AI Technical Summary
Current TCM treatments for chronic renal failure suffer from problems such as complex formulations, unclear mechanisms, and insufficient formulation stability, while Western medicine treatments are expensive, have many complications, and suffer from a shortage of kidney donors.
The formula uses the Qixiandanhuang Decoction, a traditional Chinese medicine combination. Based on the theory of traditional Chinese medicine, it addresses the root cause of "spleen and kidney deficiency" and the symptoms of "dampness and blood stasis". It is combined with Astragalus membranaceus, Epimedium, Salvia miltiorrhiza and other drugs to treat chronic renal failure by strengthening the spleen and kidney, removing blood stasis and unblocking the meridians, and eliminating turbidity and detoxifying.
It significantly reduces blood urea nitrogen, serum creatinine and urinary protein levels, alleviates microinflammatory state, and protects renal function, demonstrating good medical application value and safety.